BioSpace News Archive

Business

Dr. Michael Hayden Joins AbCellera’s Board of Directors

AbCellera, a leader in therapeutic antibody discovery from natural immune systems, has appointed Dr. Michael Hayden to its Board of Directors.

October 31, 2019
·
3 min read
Biotech Beach

Neuronoff Receives $2.2 Million Grant From National Institutes of Health to Combat Opioid Abuse

The Injectrode™ cures inside the body and is molded to the shape of the specific target.

October 31, 2019
·
1 min read
BioCapital

Pharmacist Interns Present Capstone Projects on Health Outcomes in Partnership with Allergan

Two student pharmacists participated in the competitive program, now in its 12th year.

October 31, 2019
·
2 min read
Business

AMCP Foundation and Pfizer Complete Annual Summer Internship Program in Managed Care Pharmacy

AMCP Foundation congratulates six student pharmacists from across the country who recently completed 10-week summer internships organized by the Foundation and supported by Pfizer, Inc.

October 31, 2019
·
3 min read
Deals

Number of Shares and Votes in Oncopeptides - Oct. 31, 2019

Oncopeptides AB announces that the number of shares and votes in Oncopeptides has changed as a result of exercise of warrants under the company’s incentive programs.

October 31, 2019
·
2 min read
Business

Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance

Alliance will include Roivant’s ownership interests in Myovant, Urovant, Enzyvant, Altavant, and Spirovant, a new company focused on developing innovative gene therapies for cystic fibrosis

October 31, 2019
·
7 min read
Biotech Bay

New Data: Foreign Reference Pricing Proposal in H.R. 3 Would Slash Life-Saving R&D and Lead to Destruction of California’s Life Sciences Sector

CLSA and Biocom Release Data Showing Anticipated Real-World Impact of Foreign Reference Pricing Proposed by House Democrats in H.R. 3 to Lower Drug Prices

October 31, 2019
·
10 min read
Business

Urovant Sciences Secures Substantial Financial Commitment, Commercial Infrastructure Support and Minority Shareholder Protections from Sumitomo Dainippon Pharma Upon Close of Sumitomo Dainippon Pharma’s Transaction with Roivant Sciences

Sumitomo Dainippon Pharma has committed to provide an initial $200 million, low-interest, interest-only, five-year term loan facility, with no repayments due until the end of the term

October 31, 2019
·
7 min read
Drug Development

Sirnaomics to Present Preclinical STP705 Data Suggesting Reduction in Liver Fibrosis at AASLD Liver Meeting

Monday, November 11, 12:30 – 1:30 PM

October 31, 2019
·
2 min read
Policy

Ascent Industries Corp. Default Status Report

Ascent has been filing default status reports contemplated by NP 12-203 and will continue to do so until such time that the CCAA Proceeding is concluded or until the default in making the Annual Filings is remedied.

October 31, 2019
·
4 min read